Wataru Kurosawa, Ph.D.General Manager of Business Development at Ajinomoto Bio-Pharma ServicesSpeaker
Agenda Sessions
New Ligation Approach: Technology for High Quality Manufacturing of Over 150 mer RNA
, 7:45amView Session